# Prenatal Aspirin and Postpartum Vascular Function

> **NCT05653973** · EARLY_PHASE1 · RECRUITING · sponsor: **Anna Stanhewicz, PhD** · enrollment: 60 (estimated)

## Conditions studied

- Preeclampsia
- Microvascular Function

## Interventions

- **DRUG:** Acetylcholine
- **DRUG:** Endothelin-1

## Key facts

- **NCT ID:** NCT05653973
- **Lead sponsor:** Anna Stanhewicz, PhD
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-03
- **Primary completion:** 2027-03-31
- **Final completion:** 2027-07-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05653973

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05653973, "Prenatal Aspirin and Postpartum Vascular Function". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT05653973. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*